APPROVAL OF THE NOVAVAX COVID 19 VACCINE

Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.

Learn More

last updated: March 13, 2024

Ready to Join Us?

Talk to us about questions or concerns

Monday–Saturday | 8 a.m.–8 p.m. (ET)
Sunday | 9 a.m.–5 p.m. (ET)

Already A Member?

Talk To Us About Any Questions or Concerns

Monday–Saturday | 8 a.m.–6 p.m. (ET)
Sunday | 9 a.m.–5 p.m. (ET)

Speak To Someone In Your Community

Find someone in your neighborhood and in your language